Global Health Limited has announced that its Board of Directors will meet on May 14, 2026. The primary agenda for the meeting is to consider and approve the company’s audited financial results for the quarter and financial year ended March 31, 2026. Additionally, the Board will deliberate on a recommendation for a final dividend for the 2025-26 financial year, pending approval from shareholders at the upcoming Annual General Meeting.
Upcoming Board Meeting Details
The company has scheduled its board meeting for Thursday, May 14, 2026. During this session, the leadership team will finalize the audited financial performance for the period ending March 31, 2026, which marks the close of the final quarter (Q4) of the 2025-26 fiscal year.
Dividend Consideration
In addition to reviewing financial performance, the Board of Directors will discuss and potentially recommend a final dividend for the 2025-26 financial year. Any dividend recommendation determined during this meeting will be subject to final approval by shareholders during the company’s next Annual General Meeting.
Trading Window Update
In adherence to internal compliance policies regarding insider trading, the company’s trading window has been closed since April 1, 2026. This window is set to remain closed until 48 hours after the official declaration and public release of the audited financial results.
Source: BSE
